Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-24

FDA Approved: NORPRAMIN — Supplemental Application (Validus Pharmaceuticals LLC)

View source ↗

Summary

The FDA approves a supplemental application for Norpramin (desipramine hydrochloride) submitted by Validus Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NORPRAMIN (Desipramine hydrochloride)

Snippet

SUPPL AP for NORPRAMIN (DESIPRAMINE HYDROCHLORIDE)